1. Home
  2. STG vs MREO Comparison

STG vs MREO Comparison

Compare STG & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunlands Technology Group

STG

Sunlands Technology Group

N/A

Current Price

$3.17

Market Cap

50.1M

Sector

Real Estate

ML Signal

N/A

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.32

Market Cap

50.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STG
MREO
Founded
2003
2015
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.1M
50.3M
IPO Year
2017
2017

Fundamental Metrics

Financial Performance
Metric
STG
MREO
Price
$3.17
$0.32
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$1.50
AVG Volume (30 Days)
4.0K
4.8M
Earning Date
05-21-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$500,000.00
Revenue This Year
N/A
$5,184.20
Revenue Next Year
N/A
$55.51
P/E Ratio
$1.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.44
$0.20
52 Week High
$11.53
$2.37

Technical Indicators

Market Signals
Indicator
STG
MREO
Relative Strength Index (RSI) 43.63 51.43
Support Level $3.17 $0.29
Resistance Level $3.65 $0.35
Average True Range (ATR) 0.13 0.03
MACD -0.01 0.00
Stochastic Oscillator 19.83 45.19

Price Performance

Historical Comparison
STG
MREO

About STG Sunlands Technology Group

Sunlands Technology Group operates in China's adult online education market and adult personal interest learning market through its online platforms. The Group has a deep understanding of the educational needs of its prospective students and offers solutions to help them achieve their goals. It provides online professional courses and educational content, including interest, professional skills, professional certification preparation courses, and degree- or diploma-oriented post-secondary courses. The Group adopts a counseling-oriented sales and marketing approach to offer education solutions based on students' backgrounds and goals, delivering adult online education and personal interest learning through extensive course and content offerings.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: